Acta Orthopaedica et Traumatologica Turcica, 2023 · DOI: 10.5152/j.aott.2023.22128 · Published: August 23, 2023
This study investigates whether isotretinoin and acitretin, derivatives of vitamin A used for skin diseases, can protect neural tissue after acute spinal cord injury (ASCI) in rats. Rats were divided into groups receiving either isotretinoin or acitretin for 14 or 28 days after SCI, and their motor function and spinal cord tissue were analyzed. The study found that both drugs improved motor function and reduced neuronal apoptosis, suggesting potential neuroprotective effects that could benefit patients with spinal cord injuries.
Isotretinoin and acitretin may offer a new therapeutic avenue for treating spinal cord injuries by reducing neuronal apoptosis and improving functional recovery.
Further in vitro studies and clinical trials are necessary to confirm these findings and explore the optimal dosage and treatment duration for human patients.
The neuroprotective effects of isotretinoin and acitretin suggest a possible strategy for mitigating secondary damage after spinal cord injury.